A second intriguing pathway that may be important in the setting of CHF, hypertension, and other sympathoexcitatory disorders is the modulation of the balance between the redox-sensitive transcription factors Nrf2 and NFKB. This evidence concerns the gene NFKB1 and hypertensive disorder.